STUDY OBJECTIVES: To determine whether acute changes in shielded lungs can be detected by positron emission tomography (PET) after radiation therapy. DESIGN: Retrospective cohort study. SETTING: University-affiliated medical center. PATIENTS: Sixteen patients undergoing radiation therapy for lung cancer who had PET scans after receiving treatment. INTERVENTIONS: None. MEASUREMENTS AND RESULTS: Thirteen of 16 patients (81.2%) showed increased (18)fluoro-2-deoxyglucose uptake in shielded nonirradiated lung in the following four distinct patterns: (1) contralateral peripheral pleural uptake in 5 of 16 patients (31.2%); (2) ipsilateral peripheral pleural uptake in 5 of 16 patients (31.2%); (3) bilateral peripheral pleural uptake in 1 of 16 patients (6.2%); and (4) bilateral diffuse background uptake in 1 of 16 patients (6.2%). This last patient developed clinically evident radiation pneumonitis. CONCLUSIONS: Increased lung metabolic activity can be demonstrated in the nonirradiated lung in patients who have undergone radiation therapy for lung cancer and can be detected by PET scanning. PET scanning of lungs in irradiated patients may provide an early demonstrable barometer of pulmonary toxicity. If verified, this imaging tool could prove to be useful in monitoring patients receiving radiation therapy for thoracic malignancies and may have predictive value for subsequent fibrosis. PET scanning may also be an important tool in future studies to further elucidate the pathogenetic mechanism of radiation-induced lung injury.
STUDY OBJECTIVES: To determine whether acute changes in shielded lungs can be detected by positron emission tomography (PET) after radiation therapy. DESIGN: Retrospective cohort study. SETTING: University-affiliated medical center. PATIENTS: Sixteen patients undergoing radiation therapy for lung cancer who had PET scans after receiving treatment. INTERVENTIONS: None. MEASUREMENTS AND RESULTS: Thirteen of 16 patients (81.2%) showed increased (18)fluoro-2-deoxyglucose uptake in shielded nonirradiated lung in the following four distinct patterns: (1) contralateral peripheral pleural uptake in 5 of 16 patients (31.2%); (2) ipsilateral peripheral pleural uptake in 5 of 16 patients (31.2%); (3) bilateral peripheral pleural uptake in 1 of 16 patients (6.2%); and (4) bilateral diffuse background uptake in 1 of 16 patients (6.2%). This last patient developed clinically evident radiation pneumonitis. CONCLUSIONS: Increased lung metabolic activity can be demonstrated in the nonirradiated lung in patients who have undergone radiation therapy for lung cancer and can be detected by PET scanning. PET scanning of lungs in irradiated patients may provide an early demonstrable barometer of pulmonary toxicity. If verified, this imaging tool could prove to be useful in monitoring patients receiving radiation therapy for thoracic malignancies and may have predictive value for subsequent fibrosis. PET scanning may also be an important tool in future studies to further elucidate the pathogenetic mechanism of radiation-induced lung injury.
Authors: Robert Jeraj; Yue Cao; Randall K Ten Haken; Carol Hahn; Lawrence Marks Journal: Int J Radiat Oncol Biol Phys Date: 2010-03-01 Impact factor: 7.038
Authors: Jolaine M Wilson; Jenine K Sanzari; Eric S Diffenderfer; Stephanie S Yee; John T Seykora; Casey Maks; Jeffrey H Ware; Harold I Litt; Jennifer A Reetz; James McDonough; Drew Weissman; Ann R Kennedy; Keith A Cengel Journal: Radiat Res Date: 2011-08-22 Impact factor: 2.841
Authors: Jinbo Yue; Qiuling Shi; Ting Xu; Melenda Jeter; Ting-Yu Chen; Ritsuko Komaki; Daniel R Gomez; Tinsu Pan; Charles S Cleeland; Zhongxing Liao; Xin Shelley Wang Journal: Qual Life Res Date: 2018-03-16 Impact factor: 4.147
Authors: Pegah Jahangiri; Kamyar Pournazari; Drew A Torigian; Thomas J Werner; Samuel Swisher-McClure; Charles B Simone; Abass Alavi Journal: Eur J Nucl Med Mol Imaging Date: 2018-09-18 Impact factor: 9.236
Authors: Robin Cornelissen; Suresh Senan; Imogeen E Antonisse; Hauw Liem; Youke K Y Tan; Arjan Rudolphus; Joachim G J V Aerts Journal: Radiat Oncol Date: 2007-01-03 Impact factor: 3.481
Authors: Narek Shaverdian; Maria Thor; Annemarie F Shepherd; Michael D Offin; Andrew Jackson; Abraham J Wu; Daphna Y Gelblum; Ellen D Yorke; Charles B Simone; Jamie E Chaft; Matthew D Hellmann; Daniel R Gomez; Andreas Rimner; Joseph O Deasy Journal: Cancer Med Date: 2020-05-06 Impact factor: 4.452